can i switch between tirzepatide and semaglutide Switching Tirzepatide: Efficacy, Dosing Protocols, and What to Expect Semaglutide vs. Tirzepatide for weight
Description
Dosages of semaglutide results in an average 11.85% reduction from baseline body weight after 52 weeks
(2013) Pulmonary GLP-1 Receptor Increases at Birth and Exogenous GLP-1 Receptor Agonists Augmented Surfactant-Protein Levels in Litters From Normal and Nitrofen-Treated Pregnant Rats

15 (2019): 2720, 10.3390/ijerph16152720

An alternative approach aiming to maximize the efficacy of GLP-1 involves the delivery of nuclear receptor agonists to specific tissues characterized by the expression of GLP-1R

It evaluates retatrutide in adults with obesity or overweight, testing safety and efficacy at multiple dose levels